Epidermal growth factor receptor intron-1 CA repeat polymorphism on protein expression and clinical outcome in Taiwanese oral squamous cell carcinoma
- PMID: 28694429
- PMCID: PMC5504053
- DOI: 10.1038/s41598-017-04954-5
Epidermal growth factor receptor intron-1 CA repeat polymorphism on protein expression and clinical outcome in Taiwanese oral squamous cell carcinoma
Abstract
This study was designed to explore the relationship between epidermal growth factor receptor (EGFR) CA repeats polymorphism and protein expression in oral cavity squamous cell carcinoma (OSCC). A total of 194 OSCCs were examined for EGFR protein overexpression, gene copy number and the length of their CA repeats. The length of the EGFR CA repeats was found not to be associated with EGFR gene copy number or with protein overexpression. To exclude the effect of EGFR gene copy number on protein overexpression, only those OSCC tumors with disomy of the EGFR gene were included in further analysis. In this subgroup, EGFR protein overexpression was significantly associated with poor differentiation of the tumor cells and lymph node metastasis, especially extra-capsular spread. However, EGFR CA repeats were not related to any clinicopathological factor. Interestingly, patients genetically found to have the EGFR CA repeats SS genotype and having tumors with EGFR protein overexpression were found to have a worst prognosis in terms of disease-free survival (DFS) (HR = 2.68; 95% CI, 1.03-6.98) after multivariate adjustment. The present study demonstrates that concurrent overexpression of EGFR protein in the presence genetically of the SS form CA repeats acts as a predictor for poor DFS.
Conflict of interest statement
This study was supported by Grant CMRPG391411, CMRPG3A0282, CMRPG3F0671, CMRPG3F2221 and CMRPB53 from Chang Gung Memorial Hospital, Grants NSC99-2314-B-182A-036-MY3, NSC102-2314-B-182A-081 and MOST103-2314-B-182A-057-MY2 from the Ministry of Science and Technology.
Figures
Similar articles
-
Prognostic and Clinicopathological Significance of Epidermal Growth Factor Receptor (EGFR) Expression in Oral Squamous Cell Carcinoma: Systematic Review and Meta-Analysis.Int J Mol Sci. 2023 Jul 25;24(15):11888. doi: 10.3390/ijms241511888. Int J Mol Sci. 2023. PMID: 37569265 Free PMC article.
-
Relationship between epidermal growth factor receptor gene copy number and protein expression in oral cavity squamous cell carcinoma.Oral Oncol. 2012 Jan;48(1):67-72. doi: 10.1016/j.oraloncology.2011.06.511. Epub 2011 Aug 9. Oral Oncol. 2012. PMID: 21831696
-
Lack of evidence for prognostic value of epidermal growth factor receptor intron-1 CA repeats for oral carcinomas.Eur J Oral Sci. 2017 Apr;125(2):95-101. doi: 10.1111/eos.12333. Epub 2017 Feb 2. Eur J Oral Sci. 2017. PMID: 28150908
-
EGFR copy number alterations in primary tumors, metastatic lymph nodes, and recurrent and multiple primary tumors in oral cavity squamous cell carcinoma.BMC Cancer. 2017 Aug 30;17(1):592. doi: 10.1186/s12885-017-3586-9. BMC Cancer. 2017. PMID: 28854970 Free PMC article.
-
Epidermal growth factor receptor (EGFR) in oral squamous cell carcinomas: overexpression, localization and therapeutic implications.Indian J Dent Res. 1997 Jan-Mar;8(1):9-18. Indian J Dent Res. 1997. PMID: 9495132 Review.
Cited by
-
Consistent administration of cetuximab is associated with favorable outcomes in recurrent/metastatic head and neck squamous cell carcinoma in an endemic carcinogen exposure area: a retrospective observational study.PeerJ. 2020 Sep 10;8:e9862. doi: 10.7717/peerj.9862. eCollection 2020. PeerJ. 2020. PMID: 32974098 Free PMC article.
-
Prognostic and Clinicopathological Significance of Epidermal Growth Factor Receptor (EGFR) Expression in Oral Squamous Cell Carcinoma: Systematic Review and Meta-Analysis.Int J Mol Sci. 2023 Jul 25;24(15):11888. doi: 10.3390/ijms241511888. Int J Mol Sci. 2023. PMID: 37569265 Free PMC article.
-
Epidermal growth factor receptor intron 1 polymorphism and microsatellite instability in sporadic colorectal cancer.Oncol Lett. 2021 Feb;21(2):131. doi: 10.3892/ol.2020.12392. Epub 2020 Dec 18. Oncol Lett. 2021. PMID: 33552252 Free PMC article.
-
Application of the Interaction between Tissue Immunohistochemistry Staining and Clinicopathological Factors for Evaluating the Risk of Oral Cancer Progression by Hierarchical Clustering Analysis: A Case-Control Study in a Taiwanese Population.Diagnostics (Basel). 2021 May 21;11(6):925. doi: 10.3390/diagnostics11060925. Diagnostics (Basel). 2021. PMID: 34063938 Free PMC article.
-
Early Molecular Diagnosis and Comprehensive Treatment of Oral Cancer.Curr Issues Mol Biol. 2025 Jun 12;47(6):452. doi: 10.3390/cimb47060452. Curr Issues Mol Biol. 2025. PMID: 40699851 Free PMC article. Review.
References
-
- Taiwan cancer registry, 2007 annual report (2007).
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous